Literature DB >> 27145085

Enhanced detection of respiratory pathogens with nanotrap particles.

Nazly Shafagati1, Katherine Fite1, Alexis Patanarut2, Alan Baer1, Chelsea Pinkham1, Soyeon An1, Benjamin Foote1, Benjamin Lepene2, Kylene Kehn-Hall1.   

Abstract

The Influenza virus is a leading cause of respiratory disease in the United States each year. While the virus normally causes mild to moderate disease, hospitalization and death can occur in many cases. There are several methodologies that are used for detection; however problems such as decreased sensitivity and high rates of false-negative results may arise. There is a crucial need for an effective sample preparation technology that concentrates viruses at low abundance while excluding resident analytes that may interfere with detection. Nanotrap particles are hydrogel particles that are coupled to chemical dye affinity baits that bind a broad range of proteins and virions. Within minutes (<30 minutes), Nanotrap particles concentrate low abundant proteins and viruses from clinically complex matrices. Nanotrap particles with reactive red baits concentrated numerous respiratory viruses including various strains and subtypes of Influenza virus, Coronavirus, and Respiratory Syncytial Virus from saliva, nasal fluid swab specimens, and nasal aspirates. Detection was enhanced more than 10-fold when coupled to plaque assays and qRT-PCR. Importantly, Nanotrap particle can efficiently capture and concentrate multiple viral pathogens during a coinfection scenario. These results collectively demonstrate that Nanotrap particles are an important tool that can easily be integrated into various detection methodologies.

Entities:  

Keywords:  diagnostics; influenza; nanotrap particles; respiratory pathogens; respiratory syncytial virus; viruses

Mesh:

Year:  2016        PMID: 27145085      PMCID: PMC5029303          DOI: 10.1080/21505594.2016.1185585

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  27 in total

1.  Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic.

Authors:  Niall P A S Johnson; Juergen Mueller
Journal:  Bull Hist Med       Date:  2002       Impact factor: 1.314

2.  Triazine dyes inhibit HIV-1 entry by binding to envelope glycoproteins.

Authors:  T Hattori; X Zhang; C Weiss; Y Xu; T Kubo; Y Sato; S Nishikawa; H Sakaida; T Uchiyama
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

3.  The transmembrane glycoprotein of human immunodeficiency virus type 1 induces syncytium formation in the absence of the receptor binding glycoprotein.

Authors:  L G Perez; M A O'Donnell; E B Stephens
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

Review 4.  Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease.

Authors:  Agnieszka Rynda-Apple; Keven M Robinson; John F Alcorn
Journal:  Infect Immun       Date:  2015-07-27       Impact factor: 3.441

Review 5.  Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission.

Authors:  Susan J Baigent; John W McCauley
Journal:  Bioessays       Date:  2003-07       Impact factor: 4.345

6.  Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections.

Authors:  Lay-Myint Yoshida; Motoi Suzuki; Hien Anh Nguyen; Minh Nhat Le; Thiem Dinh Vu; Hiroshi Yoshino; Wolf-Peter Schmidt; Thi Thuy Ai Nguyen; Huu Tho Le; Konosuke Morimoto; Hiroyuki Moriuchi; Duc Anh Dang; Koya Ariyoshi
Journal:  Eur Respir J       Date:  2013-05-03       Impact factor: 16.671

Review 7.  The role of infections and coinfections with newly identified and emerging respiratory viruses in children.

Authors:  Maurizia Debiaggi; Filippo Canducci; Elisa Rita Ceresola; Massimo Clementi
Journal:  Virol J       Date:  2012-10-27       Impact factor: 4.099

8.  The use of NanoTrap particles as a sample enrichment method to enhance the detection of Rift Valley Fever Virus.

Authors:  Nazly Shafagati; Aarthi Narayanan; Alan Baer; Katherine Fite; Chelsea Pinkham; Charles Bailey; Fatah Kashanchi; Benjamin Lepene; Kylene Kehn-Hall
Journal:  PLoS Negl Trop Dis       Date:  2013-07-04

Review 9.  Complications of viral influenza.

Authors:  Michael B Rothberg; Sarah D Haessler; Richard B Brown
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965

10.  Co-infections with influenza and other respiratory viruses.

Authors:  I Stefanska; M Romanowska; S Donevski; D Gawryluk; L B Brydak
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more
  8 in total

1.  Setting a trap for respiratory viruses.

Authors:  Erik A Karlsson
Journal:  Virulence       Date:  2016-06-21       Impact factor: 5.882

2.  CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses.

Authors:  Meredith C Rogers; Kristina D Lamens; Nazly Shafagati; Monika Johnson; Tim D Oury; Sebastian Joyce; John V Williams
Journal:  J Immunol       Date:  2018-07-11       Impact factor: 5.422

3.  Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection.

Authors:  Cynthia de la Fuente; Chelsea Pinkham; Deemah Dabbagh; Brett Beitzel; Aura Garrison; Gustavo Palacios; Kimberley Alex Hodge; Emanuel F Petricoin; Connie Schmaljohn; Catherine E Campbell; Aarthi Narayanan; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

4.  Use of Nanotrap particles for the capture and enrichment of Zika, chikungunya and dengue viruses in urine.

Authors:  Shih-Chao Lin; Brian D Carey; Victoria Callahan; Ji-Hyun Lee; Nicole Bracci; Anurag Patnaik; Amy K Smith; Aarthi Narayanan; Benjamin Lepene; Kylene Kehn-Hall
Journal:  PLoS One       Date:  2020-01-07       Impact factor: 3.240

5.  Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus.

Authors:  Dmitry Polyakov; Ekaterina Sinitsyna; Natalia Grudinina; Mariia Antipchik; Rodion Sakhabeev; Viktor Korzhikov-Vlakh; Mikhail Shavlovsky; Evgenia Korzhikova-Vlakh; Tatiana Tennikova
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321

6.  Magnetic Nanotrap Particles Preserve the Stability of Venezuelan Equine Encephalitis Virus in Blood for Laboratory Detection.

Authors:  Ivan Akhrymuk; Shih-Chao Lin; Mei Sun; Anurag Patnaik; Caitlin Lehman; Louis Altamura; Timothy Minogue; Ben Lepene; Monique L van Hoek; Kylene Kehn-Hall
Journal:  Front Vet Sci       Date:  2020-01-28

Review 7.  Nanotechnology-based antiviral therapeutics.

Authors:  Malobika Chakravarty; Amisha Vora
Journal:  Drug Deliv Transl Res       Date:  2021-06       Impact factor: 4.617

8.  Use of magnetic nanotrap particles in capturing Yersinia pestis virulence factors, nucleic acids and bacteria.

Authors:  Alexandra N Ii; Shih-Chao Lin; Benjamin Lepene; Weidong Zhou; Kylene Kehn-Hall; Monique L van Hoek
Journal:  J Nanobiotechnology       Date:  2021-06-21       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.